assessing the role of parp inhibitors and immunotherapy in ovarian cancer
Published 1 year ago • 267 plays • Length 2:38Download video MP4
Download video MP3
Similar videos
-
1:38
updates in parp inhibition for ovarian cancer
-
4:06
the promise of parp inhibitors and their emerging role in ovarian cancer
-
0:45
evaluating future use of parp inhibitors in neoadjuvant therapy for ovarian cancer
-
1:22
overcoming resistance to parp inhibition in ovarian cancer
-
3:09
the promising potential of parp inhibitors in ovarian cancer
-
3:45
parp inhibitors for ovarian cancer
-
3:44
the future role of parp inhibition in ovarian cancer
-
3:58
the potential of parp inhibitors in ovarian cancer: paola-1, prima & velia
-
2:30
do icis with parp inhibitors have a role in treating ovarian cancer?
-
1:53
parp inhibitors: game-changers for ovarian cancer patients?
-
2:58
standard of care updates in ovarian cancer: parp inhibitors
-
6:36
role of parp inhibition in ovarian cancer
-
6:14
standard of care and progress with parp inhibitors for ovarian cancer
-
23:32
role of parp inhibitor in ovarian cancer dr. thomas herzog
-
5:06
ovarian cancer: the role of parp inhibitors and beyond
-
59:14
parp inhibitors in ovarian cancer: clinical updates from sgo 2023
-
2:06
dr. konecny discusses the role of parp inhibitors in ovarian cancer
-
1:41
dr. parsons discusses the role of parp 7 in overall survival of patients with ovarian cancer
-
1:08
should 1l maintenance with parp inhibitors be given to all patients with ovarian cancer?